Gilead’s Lenacapavir Achieves 100% HIV Prevention in Trial News Gilead’s Lenacapavir Achieves 100% HIV Prevention in Trial admin June 21, 2024 United States: Two yearly regimens of an antiretroviral drug developed by Gilead Sciences Inc. were 100 percent... Read More Read more about Gilead’s Lenacapavir Achieves 100% HIV Prevention in Trial
